Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shawbrook testing investor sentiment for London IPO - report

(Sharecast News) - Commercial banking group Shawbrook has reportedly begun talks with institutional investors regarding the timing of a possible initial public offering in London. According to Sky News on Friday, the bank - along with part-owners BC Partners and Pollen Street Capital - have held so-called 'pilot-fishing' meetings to test investor sentiment before officially kicking off the IPO process.

The bank could attain a market cap of more than £2bn, according to the news outlet.

It was initially hoped that the business lender would return to the stock market - following a brief stint as a public company between 2015 and 2017 - in the first half of 2025, though plans were delayed until some time in the second half.

Now, according to Sky News, uncertainty regarding rumoured bank tax changes in the upcoming Autumn Budget may see the IPO being pushed out to 2026.

Recent years have seen Shawbrook engage in a number of unsuccessful attempts to take over or merge with rivals in the sector, including Metro Bank, Starling Bank and Co-op Bank.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.